Biogeneric Drugs Market Report

Global and Region Biogeneric Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：136
  • REPORT CODE：GMM904610
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Biogeneric Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Biogeneric Drugsmarket, defines the market attractiveness level of Biogeneric Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Biogeneric Drugs industry, describes the types of Biogeneric Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Biogeneric Drugs market and the development prospects and opportunities of Biogeneric Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Biogeneric Drugs market in Chapter 13.

    By Player:

    • Reliance life sciences

    • AMEGA Biotech

    • Mylan

    • Teva pharmaceutical industries

    • LG life Science

    • Dong-A Pharmaceutical

    • Sandoz International

    • Biocon

    • Shanghai Fosun Pharmaceutical

    • Celltrion

    • Biosidus

    • Tonghua Dongbao Pharmaceutical

    • Probiomed

    • 3SBio

    By Type:

    • Insulins

    • Growth Hormones

    • Monoclonal Antibodies

    • Others

    By End-User:

    • Hospital

    • Clinics

    • Research Centers

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Biogeneric Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Biogeneric Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Biogeneric Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Biogeneric Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Biogeneric Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Biogeneric Drugs Consumption (2017-2022)

    • 7.2 United States Biogeneric Drugs Consumption (2017-2022)

    • 7.3 Europe Biogeneric Drugs Consumption (2017-2022)

    • 7.4 China Biogeneric Drugs Consumption (2017-2022)

    • 7.5 Japan Biogeneric Drugs Consumption (2017-2022)

    • 7.6 India Biogeneric Drugs Consumption (2017-2022)

    • 7.7 South Korea Biogeneric Drugs Consumption (2017-2022)

    8 Region and Country-wise Biogeneric Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Biogeneric Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Biogeneric Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Biogeneric Drugs Consumption Forecast (2022-2028)

    • 8.4 China Biogeneric Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Biogeneric Drugs Consumption Forecast (2022-2028)

    • 8.6 India Biogeneric Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Biogeneric Drugs Consumption Forecast (2022-2028)

    9 Global Biogeneric Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Biogeneric Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Insulins Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Growth Hormones Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Biogeneric Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Research Centers Consumption and Growth Rate (2017-2022)

    10 Global Biogeneric Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Biogeneric Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Insulins Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Growth Hormones Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Biogeneric Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Research Centers Consumption Forecast and Growth Rate (2022-2028)

    11 Global Biogeneric Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Biogeneric Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Biogeneric Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Biogeneric Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Biogeneric Drugs Market Competitive Analysis

    • 14.1 Reliance life sciences

      • 14.1.1 Reliance life sciences Company Details

      • 14.1.2 Reliance life sciences Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Reliance life sciences Biogeneric Drugs Product and Service

    • 14.2 AMEGA Biotech

      • 14.2.1 AMEGA Biotech Company Details

      • 14.2.2 AMEGA Biotech Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 AMEGA Biotech Biogeneric Drugs Product and Service

    • 14.3 Mylan

      • 14.3.1 Mylan Company Details

      • 14.3.2 Mylan Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Mylan Biogeneric Drugs Product and Service

    • 14.4 Teva pharmaceutical industries

      • 14.4.1 Teva pharmaceutical industries Company Details

      • 14.4.2 Teva pharmaceutical industries Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Teva pharmaceutical industries Biogeneric Drugs Product and Service

    • 14.5 LG life Science

      • 14.5.1 LG life Science Company Details

      • 14.5.2 LG life Science Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 LG life Science Biogeneric Drugs Product and Service

    • 14.6 Dong-A Pharmaceutical

      • 14.6.1 Dong-A Pharmaceutical Company Details

      • 14.6.2 Dong-A Pharmaceutical Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Dong-A Pharmaceutical Biogeneric Drugs Product and Service

    • 14.7 Sandoz International

      • 14.7.1 Sandoz International Company Details

      • 14.7.2 Sandoz International Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sandoz International Biogeneric Drugs Product and Service

    • 14.8 Biocon

      • 14.8.1 Biocon Company Details

      • 14.8.2 Biocon Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Biocon Biogeneric Drugs Product and Service

    • 14.9 Shanghai Fosun Pharmaceutical

      • 14.9.1 Shanghai Fosun Pharmaceutical Company Details

      • 14.9.2 Shanghai Fosun Pharmaceutical Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Shanghai Fosun Pharmaceutical Biogeneric Drugs Product and Service

    • 14.10 Celltrion

      • 14.10.1 Celltrion Company Details

      • 14.10.2 Celltrion Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Celltrion Biogeneric Drugs Product and Service

    • 14.11 Biosidus

      • 14.11.1 Biosidus Company Details

      • 14.11.2 Biosidus Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Biosidus Biogeneric Drugs Product and Service

    • 14.12 Tonghua Dongbao Pharmaceutical

      • 14.12.1 Tonghua Dongbao Pharmaceutical Company Details

      • 14.12.2 Tonghua Dongbao Pharmaceutical Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Tonghua Dongbao Pharmaceutical Biogeneric Drugs Product and Service

    • 14.13 Probiomed

      • 14.13.1 Probiomed Company Details

      • 14.13.2 Probiomed Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Probiomed Biogeneric Drugs Product and Service

    • 14.14 3SBio

      • 14.14.1 3SBio Company Details

      • 14.14.2 3SBio Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 3SBio Biogeneric Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Biogeneric Drugs

    • Figure Biogeneric Drugs Picture

    • Table Global Biogeneric Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Biogeneric Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Biogeneric Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Biogeneric Drugs Consumption by Country (2017-2022)

    • Figure United States Biogeneric Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Biogeneric Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Biogeneric Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Biogeneric Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Biogeneric Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Biogeneric Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Biogeneric Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Biogeneric Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Biogeneric Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Biogeneric Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Biogeneric Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Biogeneric Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Biogeneric Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insulins Consumption and Growth Rate (2017-2022)

    • Figure Global Growth Hormones Consumption and Growth Rate (2017-2022)

    • Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Research Centers Consumption and Growth Rate (2017-2022)

    • Figure Global Insulins Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Growth Hormones Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Research Centers Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Biogeneric Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Biogeneric Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Reliance life sciences (Foundation Year, Company Profile and etc.)

    • Table Reliance life sciences Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Reliance life sciences Biogeneric Drugs Product and Service

    • Table AMEGA Biotech (Foundation Year, Company Profile and etc.)

    • Table AMEGA Biotech Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table AMEGA Biotech Biogeneric Drugs Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Biogeneric Drugs Product and Service

    • Table Teva pharmaceutical industries (Foundation Year, Company Profile and etc.)

    • Table Teva pharmaceutical industries Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva pharmaceutical industries Biogeneric Drugs Product and Service

    • Table LG life Science (Foundation Year, Company Profile and etc.)

    • Table LG life Science Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table LG life Science Biogeneric Drugs Product and Service

    • Table Dong-A Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Dong-A Pharmaceutical Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dong-A Pharmaceutical Biogeneric Drugs Product and Service

    • Table Sandoz International (Foundation Year, Company Profile and etc.)

    • Table Sandoz International Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sandoz International Biogeneric Drugs Product and Service

    • Table Biocon (Foundation Year, Company Profile and etc.)

    • Table Biocon Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocon Biogeneric Drugs Product and Service

    • Table Shanghai Fosun Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Shanghai Fosun Pharmaceutical Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shanghai Fosun Pharmaceutical Biogeneric Drugs Product and Service

    • Table Celltrion (Foundation Year, Company Profile and etc.)

    • Table Celltrion Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celltrion Biogeneric Drugs Product and Service

    • Table Biosidus (Foundation Year, Company Profile and etc.)

    • Table Biosidus Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biosidus Biogeneric Drugs Product and Service

    • Table Tonghua Dongbao Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Tonghua Dongbao Pharmaceutical Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tonghua Dongbao Pharmaceutical Biogeneric Drugs Product and Service

    • Table Probiomed (Foundation Year, Company Profile and etc.)

    • Table Probiomed Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Probiomed Biogeneric Drugs Product and Service

    • Table 3SBio (Foundation Year, Company Profile and etc.)

    • Table 3SBio Biogeneric Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3SBio Biogeneric Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US